Company Profile
Year Established :
1989
Main Competitive Advantages :
International Approvals/Standards,Production Capacity,Small Orders Accepted,Reputation,Quality Service
Business Type :
Manufacturer
Main Sales Markets :
Central/South America,Eastern Europe,Asia,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates
Product Range :
Active Pharmaceutical Ingredients, Intermediates.
Zhejiang Haisen Pharmaceutical Co.,Ltd. is a medium-manufacturer enterprise engaged in the R&D, production and sales of APIS, intermediates and food additives. USFDA,CEP,Cofepris,KDMF,DMF&ISO are available. With an occupied floor area of 150,000 sq.meters,a greening rate reaching 40% and an annual sales value exceeding 300 million RMB yuan, the company has more than 500 employees,36% of which are professional technicians. main APIs: Atrovastatin Calcium, Escitalopram oxalate, Metamizole Sodium, Antipyrine, Sucralfate, Paroxetine HCL, Pazufloxacin Mesilate, 3-hydroxybutyric-4-Amino acid (GABOB), Parecoxib Sodium etc.